Paul Knight
Stock Analyst at Keybanc
(1.82)
# 3,241
Out of 5,132 analysts
139
Total ratings
43.86%
Success rate
-2.8%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $509.82 | +47.11% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $243.61 | +43.67% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $3.24 | +362.96% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.00 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $140.51 | +56.57% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.24 | +82.04% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.56 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $59.54 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $319.83 | +43.83% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.11 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.81 | +110.25% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $95.57 | +51.72% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $169.53 | +147.74% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $116.02 | +98.24% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $21.58 | +52.92% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $31.90 | +12.85% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $214.94 | +44.23% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $132.63 | +65.87% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $15.60 | +137.18% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.02 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $2.13 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $124.88 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $28.12 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $9.14 | +337.64% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $158.74 | +88.99% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $168.85 | +48.06% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $104.54 | +321.85% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $142.02 | +66.17% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $81.70 | +21.18% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $14.76 | +272.63% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $35.15 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $88.63 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $114.44 | - | 5 | Oct 23, 2017 |
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $509.82
Upside: +47.11%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $243.61
Upside: +43.67%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $3.24
Upside: +362.96%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.00
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $140.51
Upside: +56.57%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.24
Upside: +82.04%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.56
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $59.54
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $319.83
Upside: +43.83%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.11
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.81
Upside: +110.25%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $95.57
Upside: +51.72%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $169.53
Upside: +147.74%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $116.02
Upside: +98.24%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $21.58
Upside: +52.92%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $31.90
Upside: +12.85%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $214.94
Upside: +44.23%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $132.63
Upside: +65.87%
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $15.60
Upside: +137.18%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.02
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $2.13
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $124.88
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $28.12
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $9.14
Upside: +337.64%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $158.74
Upside: +88.99%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $168.85
Upside: +48.06%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $104.54
Upside: +321.85%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $142.02
Upside: +66.17%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $81.70
Upside: +21.18%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $14.76
Upside: +272.63%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $35.15
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $88.63
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $114.44
Upside: -